Shared Investigator Platform (SIP)

The Shared Investigator Platform (SIP) is a technology platform that lets a clinical trial site maintain one reusable profile of investigator and site qualifications — credentials, training records, GCP certifications, CVs, facility and equipment details — and make that single profile visible to multiple participating study sponsors, instead of re-entering and re-submitting the same documentation separately for every sponsor and every study. It was originally developed by TransCelerate BioPharma, a nonprofit consortium of biopharmaceutical companies, specifically to address a well-documented site-startup burden: before platforms like SIP existed, a site running trials for several sponsors typically needed a separate login, a separate document upload process, and a separate copy of the same qualification package for each sponsor’s own portal.

Why it exists

Clinical trial sites, particularly ones that participate in many concurrent studies across different sponsors, historically absorbed significant administrative overhead from sponsor-specific systems: each sponsor or CRO commonly ran its own site portal, with its own login credentials, its own document formats, and its own process for collecting the same underlying facts about a site — who the investigators are, what training and certifications they hold, what equipment and staff the facility has. TransCelerate built SIP as a shared, sponsor-neutral layer specifically to remove that duplication: a site enters its qualification data once, in one Facility Profile, and then authorizes individual sponsors to view it rather than re-keying it into each sponsor’s separate system.

What counts as an instance (operational definition)

A site/sponsor interaction is properly described as using a shared investigator platform, in the SIP sense, when it has all three of the following:

• One central profile, not a sponsor-specific login. The site maintains a single Facility Profile and individual user profiles (credentials, CV, training and certification records) through one platform account, administered by a designated Facility Profile Manager, rather than creating a new account per sponsor.
• Reuse across sponsors by authorization, not re-entry. Once a document or credential — a current GCP certification, a license, a CV — is entered, the site authorizes it to be visible to any participating sponsor running a study there, rather than uploading a fresh copy into each sponsor’s own system.
• Study start-up and conduct activities route through the shared platform. Document exchange, study-specific training assignment, and sponsor-site communication for a given trial happen inside the shared system, not a separate sponsor-built portal layered on top of it.

Current operating status

TransCelerate’s Shared Investigator Platform Initiative reached completion in 2020; the organization states plainly that no new deliverables or updates are planned by TransCelerate itself. The platform is now owned and operated by Cognizant, which handles ongoing site and sponsor support. TransCelerate Member Companies developed SIP and can choose to adopt it for their studies, but adoption by any individual sponsor, CRO, or study remains voluntary — a site’s experience still depends on whether the specific sponsor running a given trial has chosen to use SIP for that study or continues to operate its own separate portal alongside it.

Relationship to site-startup burden more broadly

SIP addresses one specific, well-scoped piece of a larger site-startup problem: the duplication of investigator and site qualification documentation across sponsors. It does not, on its own, standardize every part of study start-up — protocol-specific training, budget negotiation, and regulatory submissions still typically involve sponsor- or study-specific steps even for a site with a complete SIP profile. It sits alongside, rather than replaces, a site’s own clinical trial management system (CTMS), which tracks study conduct and operations internally at the site or sponsor rather than serving as the shared, cross-sponsor credentialing layer SIP provides.

Related terms

• Clinical Research Associate (CRA) — the sponsor/CRO-side role most directly involved in reviewing and monitoring the site qualification documentation a platform like SIP centralizes.
• Good Clinical Practice (GCP) certification — one of the specific credential types a site’s SIP profile is built to hold and reuse across sponsors.
• Clinical Trial Management System (CTMS) — the internal system tracking study conduct, distinct from SIP’s cross-sponsor credentialing function.